Bills Committee on Undesirable Medical Advertisements (Amendment) (No.2) Bill 2004

bulletPapers

Written submissions and the Administration's response

  • Copy of joint letter dated 26 April 2005 from Hon Vincent FANG and Hon WONG Ting-kwong enclosing the proposed amendments to the Undesirable Medical Advertisements (Amendment) (No.2) Bill 2004 from the Hong Kong Association of the Pharmaceutical Industry (Chinese version only) [CB(2)1395/04-05(01)] (20 May 2005)

  • Further submission from the Consumer Council (Chinese version only) [CB(2)846/04-05(01)] (17 February 2005)

  • Further submission from the Hong Kong Association of the Pharmaceutical Industry [CB(2)948/04-05(01)] (24 February 2005)

  • Further submission from the Hong Kong Pharmaceutical Manufacturers Association Ltd. (Chinese version only) [CB(2)685/04-05(04)] (17 February 2005)

  • Further submission from the Lion Rock Institute (English version only) [CB(2)895/04-05(02)] (17 February 2005)

  • Further submission from the Modernized Chinese Medicine International Association (English version only) [CB(2)967/04-05(01)] (20 May 2005)

  • Questionnaire for the survey on the Undesirable Medical Advertisements Ordinance undertaken by the Better Hong Kong Movement Association and the Lion Rock Institute (Chinese version only) [CB(2)945/04-05(01)] (27 February 2005)

  • Submission from A.S. Watson Group (HK) Limited - PARKnSHOP (English version only) [CB(2)374/04-05(01)] (9 December 2004)

  • Submission from Mr Alexander YUEN (Chinese version only) [CB(2)630/04-05(02)] (17 January 2005)

  • Submission from Mr Yip Ming (English version only) [CB(2)251/04-05(16)] (23 November 2004)

  • Submission from Professor S K LAM of the Faculty of Medicine of the University of Hong Kong (English version only) [CB(2)434/04-05(01)] (17 January 2005)

  • Submission from the Better Hong Kong Movement Association (Chinese version only) [CB(2)630/04-05(01)] (17 January 2005)

  • Submission from the Chinese Manufacturers' Association of Hong Kong (Chinese version only) [CB(2)251/04-05(14)] (23 November 2004)

  • Submission from the Chinese Medicine Merchants Association Ltd. (Chinese version only) [CB(2)273/04-05(01)] (23 November 2004)

  • Submission from the Consumer Council [CB(2)251/04-05(09)] (23 November 2004)

  • Submission from the Democratic Party (Chinese version only) [CB(2)685/04-05(03)] (17 January 2005)

  • Submission from the Direct Selling of Hong Kong Ltd. (Chinese version only) [CB(2)251/04-05(06)] (23 November 2004)

  • Submission from the Hong Kong Academy of Medicine (English version only) [CB(2)475/04-05(01)] (17 January 2005)

  • Submission from the Hong Kong Association of The Pharmaceutical Industry [CB(2)364/04-05(02)] (9 December 2004)

  • Submission from the Hong Kong Chinese Herbalists Association Ltd. (Chinese version only) [CB(2)251/04-05(02)] (23 November 2004)

  • Submission from the Hong Kong Chinese Prepared Medicine Traders Association Ltd. (Chinese version only) [CB(2)251/04-05(03)] (23 November 2004)

  • Submission from the Hong Kong Doctors Union (English version only) [CB(2)251/04-05(12)] (23 November 2004)

  • Submission from the Hong Kong Health Food Association [CB(2)251/04-05(04)] (23 November 2004)

  • Submission from the Hong Kong Medical Association (English version only) [CB(2)259/04-05(01)] (23 November 2004)

  • Submission from the Hong Kong Medicine Dealers' Guild (Chinese version only) [CB(2)301/04-05(01)] (23 November 2004)

  • Submission from the Hong Kong Pharmaceutical Manufacturers Association Ltd. (Chinese version only) [CB(2)251/04-05(10)] (23 November 2004)

  • Submission from the Hong Kong Retail Management Association [CB(2)251/04-05(08)] (23 November 2004)

  • Submission from the Hong Kong Society of Chinese Medicines (Chinese version only) [CB(2)273/04-05(02)] (23 November 2004)

  • Submission from the Hong Kong Suppliers Association (English version only) [CB(2)251/04-05(15)] (23 November 2004)

  • Submission from the Hong Kong YEE YEE Tong Chinese Medicine Merchants Association Ltd. (Chinese version only) [CB(2)251/04-05(11)] (23 November 2004)

  • Submission from the International General Chinese Herbalists and Medicine Professionals Association Ltd. (Chinese version only) [CB(2)273/04-05(03)] (23 November 2004)

  • Submission from the Lion Rock Institute (Chinese version only) [CB(2)580/04-05(03)] (17 January 2005)

  • Submission from the Modernized Chinese Medicine International Association (Chinese version only) [CB(2)251/04-05(05)] (23 November 2004)

  • Submission from the Ocean Pharmaceutical (Hong Kong) Limited (Chinese version only) [CB(2)251/04-05(07)] (23 November 2004)

  • Submission from the Society for Community Organization (Chinese version only) [CB(2)879/04-05(01)] (17 February 2005)

  • Submission from the Society of Hospital Pharmacists of Hong Kong (English version only) [CB(2)251/04-05(13)] (23 November 2004)

  • Submission from Watson's The Chemist (Chinese version only) [CB(2)301/04-05(02)] (23 November 2004)

  • The Administration's response to submissions of the deputations (Chinese version only) [CB(2)1602/04-05(01)] (20 May 2005)

  • The Administration's response to the submission of UMAO Coalition (Chinese version only) [CB(2)1624/04-05(01)] (20 May 2005)